Trump Orders New NIH Women’s Health Division: What Nurses Need to Know

Image source: USA Today

President Donald Trump on Monday signed an executive order directing the National Institutes of Health (NIH) to create a new Women’s Health Division, a move the administration says will close long-standing research gaps on conditions that hit women hardest. First Lady Melania Trump championed the order.

The order, titled Advancing Women’s Health to Improve Outcomes in All Phases of Life, gives NIH 90 days to stand up the division. It also creates the first White House Women’s Health Task Force, co-chaired by HHS Secretary Robert F. Kennedy Jr. and White House Chief of Staff Susie Wiles, who recently completed treatment for breast cancer.

Want to see more Nurse.org articles in your Google results? Add us as a preferred source.

For nurses who care for women at every stage of life, from labor and delivery to cardiac and oncology units, the order could eventually change the research behind the care you provide.

Melania Trump framed the initiative around what she called the “Five Pillars of Women’s Health Innovation”: directing research funding toward conditions that affect women uniquely, using artificial intelligence to speed medical discoveries, accelerating women’s access to new treatments, making those treatments affordable, and replacing silence around women’s health with open conversation.

“Beginning today, we will change the reality of women’s health,” Melania Trump said at the Rose Garden signing. “Previous generations fought for women’s rights. Our generation will fight to discover the cures that will ensure a woman can live her life in health and to the fullest.”

According to HHS, the new division will work with the existing NIH Office of Research on Women’s Health. It will study conditions that uniquely or disproportionately affect women, including,

• Cardiovascular disease
• Cancer
• Autoimmune and inflammatory conditions
• Chronic pain
• Endometriosis
• Fibroids
• Polyendocrine metabolic ovarian syndrome (PMOS)
• Infertility
• Maternal health
• Menopause
• Alzheimer’s disease
• Osteoporosis

PMOS is the new name for polycystic ovary syndrome (PCOS), endorsed in May 2026 after an international consensus effort published in The Lancet, with a three-year transition period toward full adoption.

The order itself directs the division to:

• Increase scientific review of understudied women’s health conditions
• Support replication studies and personalized medicine
• Increase inclusion of women and girls in clinical trials
• Enforce NIH’s requirement that funded researchers account for sex as a biological variable
• Move scientific discoveries into clinical practice

The task force will include the secretaries of War, Agriculture, Labor, Education, and Veterans Affairs, plus the leaders of the EPA, FDA, CDC, NIH, ARPA-H, and CMS. Other members may be invited to participate at the discretion of the co-chairs. The mandate covers clinical education, integrated care, and pilot programs.

“For generations, women have faced unanswered questions about conditions that uniquely or disproportionately affect them. This new NIH division will confront those questions with gold-standard science, accelerate research into prevention and treatment, and turn medical discoveries into better care for women and girls across America,” Kennedy said in the statement.

NIH Director Jay Bhattacharya said the division “will help close lingering evidence gaps, expand and maximize the impact of our research investments, and bring discoveries closer to patients.”

>>Listen to The Latest Nurse News Podcast

No New Money, and a Biden Order Revoked

What the order does not include matters just as much. It specifies no new funding. All actions are “subject to the availability of appropriations,” according to the order, and CBS News reported it is not yet clear how much money will go toward research, therapies, or affordability.

The order also revokes Executive Order 14120, President Joe Biden’s March 2024 order on advancing women’s health research and innovation, along with a related November 2023 presidential memorandum.

Source: USA Today

The announcement sits uneasily against the administration’s broader record on NIH. STAT reported that earlier in the Trump administration, NIH grants containing the word “women” triggered special reviews, and some researchers said their work was swept into “gender ideology” restrictions and broader funding cuts. The administration has also moved to let political appointees play a larger role in health research funding decisions. Whether a new Women’s Health Division survives those pressures, or is shaped by them, is the open question nurses should watch as the January 2027 deadline approaches.

The structure, leadership, and budget of the new division have not been disclosed. HHS has confirmed it will not replace the existing Office of Research on Women’s Health, established in 1990, but will work alongside it.

HHS framed the order as building on its own work since January 2025. That includes,

• Removing broad boxed warnings from hormone replacement therapy products
• Approving the first generic version of Premarin in more than 30 years
• Launching Moms.gov
• Investing more than $525 million in home visiting services
• Proposing cervical cancer screening guidelines that include a self-collection option

This order does not change nurses’ scope of practice, licensure, or pay. Its impact will show up more slowly, in the evidence that shapes protocols, patient education, and screening guidelines. Healthcare workers might not even see any effects for several years. Hospitals also have to adopt any of the changes.

🤔 Nurses, what women’s health condition do you think has been ignored the longest in research? Will a new NIH division make a difference at the bedside? Share your thoughts in the comments.